RCM
MIST icon

RA Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

RA Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,246,503
Closed -$20.6M – 75
2022
Q3 		$20.6M Hold
2,246,503
– – 0.44% 49
2022
Q2 		$13.8M Hold
2,246,503
– – 0.37% 54
2022
Q1 		$14.4M Hold
2,246,503
– – 0.31% 66
2021
Q4 		$14.7M Hold
2,246,503
– – 0.26% 65
2021
Q3 		$12.8M Hold
2,246,503
– – 0.18% 69
2021
Q2 		$12.4M Hold
2,246,503
– – 0.2% 67
2021
Q1 		$13M Sell
2,246,503
-81,211
-3% -$594K 0.2% 64
2020
Q4 		$15.6M Sell
2,327,714
-91,084
-4% -$610K 0.22% 61
2020
Q3 		$17.7M Buy
+2,418,798
New +$17.3M 0.32% 53

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RA Capital Management's MIST Position: Q4 2022 in Review

RA Capital Management sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 2,246,503 shares — an estimated $20.6M sold.

RA Capital Management first reported a position in MIST in Q3 2020 and held it in 9 quarters. The position peaked at $20.6M in Q3 2022. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

  • RA Capital Management reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • RA Capital Management sold 2,246,503 Milestone Pharmaceuticals shares in Q4 2022, an estimated $20.6M.
  • RA Capital Management first reported a position in Milestone Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • RA Capital Management's Milestone Pharmaceuticals position peaked at $20.6M in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.